TAGline Spring 2018: Bend the curves
Treatment Action Group releases the spring issue of TAGline, Bend the curves: Activism and the elimination of HIV, HCV, and TB.
Incremental change—activism that successfully defends or advances critical research or policy—can sometimes feel inconsequential, particularly when it is hard won, resource intensive, and intangible. But in the context of public health strategies with ambitious targets and formidable stakeholder engagement, it is an undeniable facet of progress. In this issue of TAGline, Treatment Action Group (TAG) highlights some important recent successes and challenges in meeting its overarching goals: moving beyond achingly slow trends and sharply bending the curves on new HIV, hepatitis C, and TB infections, suffering, and deaths.
Spring TAGline contains:
- The Usual Suspects:
Common Challenges for ETE Planning and Implementation in Emerging Jurisdictions
By Jeremiah Johnson
- New York State EtE Campaign Update:
Successes & Challenges
By Jeremiah Johnson
- The Role of Vaccines and Cures in HIV Elimination
By RIchard Jefferys
- It’s up to You, New York:
Moving towards HCV Elimination in the Empire State
By Annette Gaudino
- Global HCV Elimination Targets and Challenges:
An Interview with Andrew Hill
By Bryn Gay & Annette Gaudino
- From Moscow to New York and Beyond:
The Future of Tuberculosis Research and Development
By Safiqa Khimani and Mark Harrington
- In a State of Disunion:
HIV, TB, and HCV Elimination Policies and Priorities Under the Trump Administration
By Suraj Madoori
Source: Treatment Action Group